In vivo gene therapy potentials of CRISPR-Cas9.

Xue, H-Y; Zhang, X; Wang, Y; Xiaojie, L; Dai, W-J; Xu, Y

Xue, H-Y; Zhang, X; Wang, Y; Xiaojie, L; Dai, W-J; Xu, Y.

Afiliação

Xue HY; The Reproductive Center, Jiangsu Huai'an Maternity and Children Hospital, Huai'an, China.
Zhang X; Department of Medical Imaging, The Fourth People's Hospital of Huai'an, Huai'an, Jiangsu, China.
Wang Y; Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Xiaojie L; Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Dai WJ; Department of Gastroenterology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, Jiangsu, China.
Xu Y; Department of Nephrology, The Affiliated Huai'an Hospital of Xuzhou Medical College and The Second People's Hospital of Huai'an, Huai'an, China.

Gene Ther ; 23(7): 557-9, 2016 07.

Article em En | MEDLINE | ID: mdl-27029608

Assuntos

Sistemas CRISPR-Cas; Terapia Genética/métodos; Animais; Modelos Animais de Doenças; Edição de Genes; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia Genética / Sistemas CRISPR-Cas Limite: Animals / Humans Idioma: En Revista: Gene Ther Assunto da revista: GENETICA MEDICA / TERAPEUTICA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google